Immediate invasive therapy for AMI presenting >12 hours after symptom onset was associated with a non-significant trend toward decreased in-hospital mortality (OR 0.73; 95% CI 0.53-1.01).
Observational
Yes
Does immediate invasive therapy improve in-hospital outcomes compared to conservative therapy in patients presenting with AMI >12 hours after chest pain onset?
In patients presenting with late STEMI (>12 hours), the apparent mortality benefit of early invasive therapy is largely driven by selection bias, with propensity-matched multivariate analysis showing only a non-significant trend toward improved survival.
Effect estimate: OR 0.73 (95% CI 0.53-1.01)
Absolute Event Rate: 3.5% vs 5%
p-value: p=0.036
OBJECTIVES: This study was designed to compare the in-hospital outcome of patients presenting with >12 h from onset of chest pain and acute ST elevation myocardial infarction (AMI) who received either immediate invasive or conservative therapy. BACKGROUND: The benefits of fibrinolytic therapy diminish in patients presenting with AMI and onset of chest pain >12 h. Primary angioplasty has been suggested as a possible treatment for such patients, but they have been excluded from most trials of primary angioplasty. It remains unclear if an invasive treatment strategy is beneficial to these patients. METHODS: Patients presenting with >12 h of chest pain and AMI were identified from the National Registry of Myocardial Infarction 2 database. Patients receiving invasive therapy 12 h may benefit from early invasive therapy. These patients could be characterized in a randomized trial.
Elad et al. (Fri,) conducted a observational in Acute ST elevation myocardial infarction (AMI) presenting >12 h after chest pain onset. Immediate invasive therapy vs. Conservative therapy was evaluated on In-hospital mortality (OR 0.73, 95% CI 0.53-1.01, p=0.036). Immediate invasive therapy for AMI presenting >12 hours after symptom onset was associated with a non-significant trend toward decreased in-hospital mortality (OR 0.73; 95% CI 0.53-1.01).